Indivior Pharmaceuticals annual debt-to-assets ratio
2021
2022
2023
2024
2025
Indivior Pharmaceuticals Debt-to-Assets Ratio Growth & History (INDV)
Indivior Pharmaceuticals's debt-to-assets ratio was 0.29 for fiscal 2025.
View full Indivior Pharmaceuticals company overviewIndivior Pharmaceuticals annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.29 | 0.01 | +2.56% |
| 2024 | 2024-12-31 | 0.28 | 0.06 | +26.18% |
| 2023 | 2023-12-31 | 0.23 | 0.02 | +10.66% |
| 2022 | 2022-12-31 | 0.20 | 0.01 | +3.85% |
| 2021 | 2021-12-31 | 0.20 | — | — |
Indivior Pharmaceuticals quarterly debt-to-assets ratio
Q4.22
Q4.23
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.41 | 0.16 | +63.77% |
| Q1 2026 | 2026-03-31 | 0.43 | 0.16 | +58.02% |
| Q4 2025 | 2025-12-31 | 0.29 | 0.01 | +2.56% |
| Q3 2025 | 2025-09-30 | 0.25 | — | — |
| Q2 2025 | 2025-06-30 | 0.25 | — | — |
| Q1 2025 | 2025-03-31 | 0.27 | — | — |
| Q4 2024 | 2024-12-31 | 0.28 | 0.06 | +26.18% |
| Q4 2023 | 2023-12-31 | 0.23 | 0.02 | +10.66% |
| Q4 2022 | 2022-12-31 | 0.20 | — | — |
Indivior Pharmaceuticals debt-to-assets ratio trends
Between the periods ended 2021-12-31 and 2025-12-31, Indivior Pharmaceuticals's debt-to-assets ratio increased from 0.20 to 0.29, a change of 0.10. The latest reported quarter, Q2 2026, shows 0.41.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Indivior Pharmaceuticals source filings ↗